These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6528052)
1. [Use of precipitation methods of separating lipoprotein fractions for the diagnosis and differentiation of hyperlipoproteinemia types II and IV]. Bobilewicz D; Kotlicka J Przegl Lek; 1984; 41(11):647-50. PubMed ID: 6528052 [No Abstract] [Full Text] [Related]
2. [Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia]. Nowicka G; Kłosiewicz-Latoszek L Wiad Lek; 1985 Aug; 38(16):1179-84. PubMed ID: 4082589 [No Abstract] [Full Text] [Related]
3. Hypercholesterolemia in childhood. West RJ; Lloyd JK Adv Pediatr; 1979; 26():1-34. PubMed ID: 396772 [No Abstract] [Full Text] [Related]
4. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558 [TBL] [Abstract][Full Text] [Related]
5. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV. Lopez Rodriguez J; Martorell J Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061 [TBL] [Abstract][Full Text] [Related]
6. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals]. Hutt V; Klör HU; Wechsler JG; Ditschuneit H J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054 [TBL] [Abstract][Full Text] [Related]
7. Laboratory-based assessment of plasma lipids and lipoproteins for the classification of familial hypercholesterolemic and hypertriglyceridemic states. Demacker PN Semin Vasc Med; 2004 Feb; 4(1):13-22. PubMed ID: 15199429 [TBL] [Abstract][Full Text] [Related]
10. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias. Canzler H; Bojanovski D Artery; 1980; 8(2):171-8. PubMed ID: 7458684 [TBL] [Abstract][Full Text] [Related]
11. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Noseda G; Fragiacomo C; Weidmann P; Bachmann C Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660 [TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations. Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489 [TBL] [Abstract][Full Text] [Related]
13. [Preliminary evaluation of the usefulness of determination of apolipoprotein B. cholesterol and VLDL triglyceride concentrations in the early diagnosis of type IV hyperlipoproteinemia]. Bobilewicz D; Kotlicka J; Grajnert K Pol Tyg Lek; 1981 Mar; 36(9):325-6. PubMed ID: 7267451 [No Abstract] [Full Text] [Related]
14. [Primary hyperlipoproteinemia type IV and V in 3 young children]. Karczewska K; Bobilewicz D; Kasner J; Smigla K; Torbus O; Sliwa F Pediatr Pol; 1980 Dec; 55(12):1331-9. PubMed ID: 7243406 [No Abstract] [Full Text] [Related]
15. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV]. Sommariva D; Scotti L; Baroni L; Beggi P; Fasoli A Clin Ter; 1980 Mar; 92(6):649-55. PubMed ID: 7460493 [No Abstract] [Full Text] [Related]
16. [Data on repeated studies on the blood lipid levels in evaluating the severity of chronic ischemic heart disease]. Shipilova TV Kardiologiia; 1983 Feb; 23(2):85-8. PubMed ID: 6842955 [TBL] [Abstract][Full Text] [Related]
17. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Artery; 1980; 8(2):113-9. PubMed ID: 7458676 [TBL] [Abstract][Full Text] [Related]